Winter MP, Kleber ME, Koller L, Sulzgruber P, Scharnagl H, Delgado G, Goliasch G, März W et al.
Among 370 HFpEF patients in LURIC followed for 9.7 years, tPA/PAI-1 complex predicted all-cause mortality (HR 1.24 per 1 SD, 95% CI 1.04-1.47) and cardiovascular mortality (HR 1.26, 95% CI 1.02-1.56) independently of cardiovascular risk factors and NT-proBNP. It also provided incremental prognostic value above NT-proBNP (IDI 0.0157, p = 0.017), suggesting that tPA/PAI-1 complex may usefully complement traditional heart failure biomarkers in clinical HFpEF risk assessment.
Thrombosis and Haemostasis, 15. Dezember 2016 | PMID 27975104